BIOMAT Database Logo BIOMAT Database Logo

Combination treatment of clozapine and topiramate in resistant rapid-cycling bipolar disorder. 2005

Chin-Kang Chen, and I-Shin Shiah, and Chin-Bin Yeh, and Wei-Chung Mao, and Chuan-Chia Chang
Department of Psychiatry, Tri-Service General Hospital, Taipei, Taiwan.

Several open-label studies or case reports have suggested the effectiveness of clozapine or topiramate in the treatment of resistant rapid-cycling bipolar patients, but none of these publications report the long-term effectiveness of these two agents in combination. The authors present a 38-year-old woman with a 22-year history of rapid-cycling bipolar I disorder who failed to respond satisfactorily to various somatic therapies, including combination therapy for complex regimens and a course of bilateral electroconvulsive therapy, but finally responded well to a combination treatment of clozapine and topiramate. Such a combination therapy led the patient to a complete remission for more than 3 years without inducing side effects such as weight gain, hyperglycemia, type II diabetes mellitus, or hyperlipidemia. In addition, she had a weight loss of 12 kg over the past 3 years. This case suggests that the combination treatment of clozapine and topiramate can be safe and effective in some resistant rapid-cycling bipolar patients.

UI MeSH Term Description Entries
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011569 Psychiatric Status Rating Scales Standardized procedures utilizing rating scales or interview schedules carried out by health personnel for evaluating the degree of mental illness. Factor Construct Rating Scales (FCRS),Katz Adjustment Scales,Lorr's Inpatient Multidimensional Psychiatric Rating Scale,Wittenborn Scales,Edinburgh Postnatal Depression Scale,Mini International Neuropsychiatric Interview
D003024 Clozapine A tricylic dibenzodiazepine, classified as an atypical antipsychotic agent. It binds several types of central nervous system receptors, and displays a unique pharmacological profile. Clozapine is a serotonin antagonist, with strong binding to 5-HT 2A/2C receptor subtype. It also displays strong affinity to several dopaminergic receptors, but shows only weak antagonism at the dopamine D2 receptor, a receptor commonly thought to modulate neuroleptic activity. Agranulocytosis is a major adverse effect associated with administration of this agent. Clozaril,Leponex
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D005260 Female Females
D005632 Fructose A monosaccharide in sweet fruits and honey that is soluble in water, alcohol, or ether. It is used as a preservative and an intravenous infusion in parenteral feeding. Levulose,Apir Levulosa,Fleboplast Levulosa,Levulosa,Levulosa Baxter,Levulosa Braun,Levulosa Grifols,Levulosa Ibys,Levulosa Ife,Levulosa Mein,Levulosado Bieffe Medit,Levulosado Braun,Levulosado Vitulia,Plast Apyr Levulosa Mein,Levulosa, Apir,Levulosa, Fleboplast
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000077236 Topiramate A sulfamate-substituted fructose analog that was originally identified as a hypoglycemic agent. It is used for the treatment of EPILEPSY and MIGRAINE DISORDERS, and may also promote weight loss. 2,3-4,5-bis-O-(1-methylethylidene)-beta-D-fructopyranose sulfamate,Epitomax,McN 4853,McN-4853,Topamax,USL255,McN4853
D001714 Bipolar Disorder A major affective disorder marked by severe mood swings (manic or major depressive episodes) and a tendency to remission and recurrence. Affective Psychosis, Bipolar,Bipolar Disorder Type 1,Bipolar Disorder Type 2,Bipolar Mood Disorder,Depression, Bipolar,Manic Depression,Manic Disorder,Manic-Depressive Psychosis,Psychosis, Manic-Depressive,Type 1 Bipolar Disorder,Type 2 Bipolar Disorder,Psychoses, Manic-Depressive,Bipolar Affective Psychosis,Bipolar Depression,Bipolar Disorders,Bipolar Mood Disorders,Depression, Manic,Depressions, Manic,Disorder, Bipolar,Disorder, Bipolar Mood,Disorder, Manic,Manic Depressive Psychosis,Manic Disorders,Mood Disorder, Bipolar,Psychoses, Bipolar Affective,Psychoses, Manic Depressive,Psychosis, Bipolar Affective,Psychosis, Manic Depressive
D014150 Antipsychotic Agents Agents that control agitated psychotic behavior, alleviate acute psychotic states, reduce psychotic symptoms, and exert a quieting effect. They are used in SCHIZOPHRENIA; senile dementia; transient psychosis following surgery; or MYOCARDIAL INFARCTION; etc. These drugs are often referred to as neuroleptics alluding to the tendency to produce neurological side effects, but not all antipsychotics are likely to produce such effects. Many of these drugs may also be effective against nausea, emesis, and pruritus. Antipsychotic,Antipsychotic Agent,Antipsychotic Drug,Antipsychotic Medication,Major Tranquilizer,Neuroleptic,Neuroleptic Agent,Neuroleptic Drug,Neuroleptics,Tranquilizing Agents, Major,Antipsychotic Drugs,Antipsychotic Effect,Antipsychotic Effects,Antipsychotics,Major Tranquilizers,Neuroleptic Agents,Neuroleptic Drugs,Tranquillizing Agents, Major,Agent, Antipsychotic,Agent, Neuroleptic,Drug, Antipsychotic,Drug, Neuroleptic,Effect, Antipsychotic,Major Tranquilizing Agents,Major Tranquillizing Agents,Medication, Antipsychotic,Tranquilizer, Major

Related Publications

Chin-Kang Chen, and I-Shin Shiah, and Chin-Bin Yeh, and Wei-Chung Mao, and Chuan-Chia Chang
Clozapine in rapid cycling bipolar disorder.
February 1996, Journal of clinical psychopharmacology,
Chin-Kang Chen, and I-Shin Shiah, and Chin-Bin Yeh, and Wei-Chung Mao, and Chuan-Chia Chang
Clozapine prophylaxis in rapid cycling bipolar disorder.
December 1991, Journal of clinical psychopharmacology,
Chin-Kang Chen, and I-Shin Shiah, and Chin-Bin Yeh, and Wei-Chung Mao, and Chuan-Chia Chang
[Clozapine in the treatment of refractory rapid cycling bipolar disorder].
January 1996, L'Encephale,
Chin-Kang Chen, and I-Shin Shiah, and Chin-Bin Yeh, and Wei-Chung Mao, and Chuan-Chia Chang
The long-term effectiveness of clozapine and lamotrigine in a patient with treatment-resistant rapid-cycling bipolar disorder.
December 2010, Journal of psychopharmacology (Oxford, England),
Chin-Kang Chen, and I-Shin Shiah, and Chin-Bin Yeh, and Wei-Chung Mao, and Chuan-Chia Chang
Clozapine treatment of nonpsychotic rapid cycling bipolar disorder: a report of three cases.
September 1994, Biological psychiatry,
Chin-Kang Chen, and I-Shin Shiah, and Chin-Bin Yeh, and Wei-Chung Mao, and Chuan-Chia Chang
Treatment of rapid-cycling bipolar disorder.
January 2006, The Journal of clinical psychiatry,
Chin-Kang Chen, and I-Shin Shiah, and Chin-Bin Yeh, and Wei-Chung Mao, and Chuan-Chia Chang
Treatment of rapid-cycling bipolar disorder.
February 2004, CNS spectrums,
Chin-Kang Chen, and I-Shin Shiah, and Chin-Bin Yeh, and Wei-Chung Mao, and Chuan-Chia Chang
[Effectiveness and safety of topiramate in treatment-resistant bipolar disorder].
January 2001, Actas espanolas de psiquiatria,
Chin-Kang Chen, and I-Shin Shiah, and Chin-Bin Yeh, and Wei-Chung Mao, and Chuan-Chia Chang
Nimodipine treatment of rapid cycling bipolar disorder.
July 1995, The Journal of clinical psychiatry,
Chin-Kang Chen, and I-Shin Shiah, and Chin-Bin Yeh, and Wei-Chung Mao, and Chuan-Chia Chang
Biological treatment of rapid-cycling bipolar disorder.
September 1996, Pharmacopsychiatry,
Copied contents to your clipboard!